Fosaprepitant dimeglumine/palonosetron hydrochloride

1）主要研究目的：评价受试制剂与参比制剂在健康人体内的药代动力学及相对生物利用度。 2）次要研究目的：评估不良事件（AE），并评估研究药物的安全性和耐受性。

The study is an open label, randomized, balanced, two period, two sequence, crossover, single dose, relative bioavailability study in healthy subjects.Each subject, meeting all the inclusion criteria and none of the exclusion criteria, will receive test product or reference product in a crossover manner based on randomization schedule. A balance between T-R and R-T randomization sequence will be ensured using statistical techniques. Blood samples for PK assessment will be collected prior to and after start of intravenous infusion on Day 1 (Period I), Day 15 (Period II).